Suchergebnisse - "Shah, Rashmi R"

PubPharm (147)

31

Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

enthalten in: Drug safety | 2017

von Shah, R.

32

Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?

enthalten in: Drug safety | 2017

von Shah, R.

33

Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?

enthalten in: Drug safety | 2016

von Shah, R.

34

Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease : Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas

enthalten in: Drug safety | 2016

von Shah, R.

35

Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas

enthalten in: Medical toxicology | 2016

von Shah, R.

36

Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas

enthalten in: Drug safety | 2016

von Shah, R.

37

Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel H3-receptor antagonist/inverse agonist

enthalten in: European journal of clinical pharmacology | 2016

von Shah, R. | Maison-Blanche, P. | Robert, P. | +2

38

Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel $ H_{3} $-receptor antagonist/inverse agonist

enthalten in: European journal of clinical pharmacology | 2016

von Shah, R. | Maison-Blanche, P. | Robert, P. | +2

39

Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel $ H_{3} $-receptor antagonist/inverse agonist

enthalten in: European journal of clinical pharmacology | 2016

von Shah, R. | Maison-Blanche, P. | Robert, P. | +2

40

Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel $ H_{3} $-receptor antagonist/inverse agonist

enthalten in: European journal of clinical pharmacology | 2016

von Shah, R. | Maison-Blanche, P. | Robert, P. | +2